Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1

Ann Rheum Dis. 2019 Jul;78(7):e67. doi: 10.1136/annrheumdis-2018-213677. Epub 2018 Jun 1.

Jean-Marie Michot^{1

2}, Mathilde Fusellier¹, Stephane Champiat^{1

3}, Charles Velter⁴, Capucine Baldini^{1

3}, Anne-Laure Voisin⁵, Francois-Xavier Danlos¹, Yolla El Dakdouki¹, Maxime Annereau⁶, Xavier Mariette⁷, Caroline Robert⁴, Khadija Cherif⁸, Aurélien Marabelle¹, Christine Mateus⁴, Olivier Lambotte^{2

3

9

10}

¹ Medical Oncology and Drug Development Department, Institut Gustave Roussy, Villejuif, France.
² Department of Internal Medicine and Clinical Immunology, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
³ University of Paris Sud, Le Kremlin-Bicêtre, France.
⁴ Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
⁵ Department of Pharmacovigilance, Institut Gustave Roussy, Villejuif, France.
⁶ Department of Pharmacy, Institut Gustave Roussy, Villejuif, France.
⁷ Department of Rheumatology, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
⁸ Department of Biopathology, Institut Gustave Roussy, Villejuif, France.
⁹ INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin- Bicêtre, France.
¹⁰ Commissariat à l'Energie Atomique (CEA), Fontenay-aux-Roses, France.

No abstract available

Keywords: autoimmunity; multidisciplinary team care; systemic lupus erythematosus.

Publication types